State Street Corp Bio Xcel Therapeutics, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 77,149 shares of BTAI stock, worth $178,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,149
Previous 77,149
-0.0%
Holding current value
$178,214
Previous $47,000
40.43%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BTAI
# of Institutions
51Shares Held
8.69MCall Options Held
22.2KPut Options Held
27.7K-
Armistice Capital, LLC New York, NY4.32MShares$9.97 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$720,6390.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $64.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...